- Home
- INTT vs AVTX Comparison
INTT vs AVTX Comparison
Compare INTT & AVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INTT
- AVTX
- Stock Information
- Founded
- INTT 1981
- AVTX 2011
- Country
- INTT United States
- AVTX United States
- Employees
- INTT N/A
- AVTX N/A
- Industry
- INTT Semiconductors
- AVTX Biotechnology: Pharmaceutical Preparations
- Sector
- INTT Technology
- AVTX Health Care
- Exchange
- INTT Nasdaq
- AVTX Nasdaq
- Market Cap
- INTT 77.3M
- AVTX 57.4M
- IPO Year
- INTT 1997
- AVTX 2015
- Fundamental
- Price
- INTT $7.53
- AVTX $4.89
- Analyst Decision
- INTT Strong Buy
- AVTX Strong Buy
- Analyst Count
- INTT 2
- AVTX 7
- Target Price
- INTT $12.00
- AVTX $31.00
- AVG Volume (30 Days)
- INTT 29.8K
- AVTX 83.5K
- Earning Date
- INTT 08-01-2025
- AVTX 08-11-2025
- Dividend Yield
- INTT N/A
- AVTX N/A
- EPS Growth
- INTT N/A
- AVTX N/A
- EPS
- INTT N/A
- AVTX N/A
- Revenue
- INTT $127,503,000.00
- AVTX $441,000.00
- Revenue This Year
- INTT N/A
- AVTX N/A
- Revenue Next Year
- INTT $10.07
- AVTX N/A
- P/E Ratio
- INTT N/A
- AVTX $0.71
- Revenue Growth
- INTT 5.19
- AVTX N/A
- 52 Week Low
- INTT $5.24
- AVTX $3.39
- 52 Week High
- INTT $11.92
- AVTX $16.00
- Technical
- Relative Strength Index (RSI)
- INTT 58.40
- AVTX 54.89
- Support Level
- INTT $7.01
- AVTX $4.63
- Resistance Level
- INTT $8.14
- AVTX $5.02
- Average True Range (ATR)
- INTT 0.45
- AVTX 0.27
- MACD
- INTT 0.02
- AVTX 0.00
- Stochastic Oscillator
- INTT 63.38
- AVTX 72.73
About INTT inTest Corporation
inTest Corp is a supplier of test and process solutions for use in manufacturing and testing across a range of markets including automotive, defense/aerospace, industrial, medical, semiconductor and telecommunications. The company manages its business as three operating segments which is also their reporting units that includes Electronic Test, Environmental Technologies and Process Technologies. Electronic Test (which includes semiconductor test equipment, flying probe and in-circuit testers), Environmental Technologies (which includes its thermal test, process and storage products) and Process Technologies (which includes induction heating and video imaging products). The company operates their business and sells its products both domestically and internationally.
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).